Our commitment is to turn our efforts into research, with passion, competence and boldness.

Take a closer look at our management team by clicking the single profiles.


    Sergio Dompé

    Executive President

    Born in Milan in 1955, Sergio Dompé is an entrepreneur in the pharmaceutical and biotechnological industries and President of Dompé, a pharmaceutical group developing innovative therapeutic solutions for rare and orphan diseases.

    He has awarded honorary doctorates in Biotechnology with specialization in pharmaceutics (Bologna, 1996), Medical Biotechnology (L’Aquila, 2005) and Pharmacy (Urbino, 2010).

    Among the first in Italy to grasp the true value of biotechnology applied to human health, he has developed an extensive network of partnerships with the most significant research centres for diseases in Dompé’s main therapeutic fields.

    In 2016, he funded and established Movendo, an innovative medical company sparkled by an idea by the Italian Institute of Technology: to develop the most advanced technologies at the service of mankind and products in the field of physical movement rehabilitation.

    In 2004 he was awarded the “La Lombardia per il lavoro” prize, in recognition of his value as one of Lombardy’s most innovative entrepreneurs.

    In 2016, he received the Prize of the Foundation Aiuto per la Ricerca sulle Malattie Rare (A.R.M.R.), regularly awarded to those who distinguish themselves in the research field.

    In 2017 he was awarded the Guido Carli prize.

    Institutional offices held

    • From 1998 to 2004: President of Assobiotec
    • Since 2004, anchor investor in Philogen, a leader in the research and development of antibodies
    • From 2005 to 2011: President of Farmindustria
    • From 2006 to 2011: Chairman of the Evaluation Committee of the CNR (Consiglio Nazionale delle Ricerche, National Research Council).
    • From 2007 to 2015: member of the Board of the IIT (Italian Institute of Technology) Foundation
    • From 2014 to 2016: member of the Patent Experts Committee of the CNR
    • From 2014 to 2016: member of the Board of Regency of the Bank of Italy (Milan office)
    • Since 2015: member of the General Council of Confindustria as representative of Farmindustria
    • Since 2016: Censor of the Bank of Italy (Milan office)
    • Since 2019: Vice President of Assolombarda with delegated powers over Life Sciences
    • 2020: Chairman of the 2021 B20 Life Sciences task-force.
  • NATHALIE 2021 2

    Nathalie Dompé

    Co-CEO Dompé farmaceutici - Vice President Business Development Dompé US

    Nathalie Dompé is Co-CEO of Dompé farmaceutici and Vice President of Business Development of the Dompé group. Nathalie is responsible for the oversight, market development, and strategic approval of all new drugs launched by Dompé in the United States. She explores new opportunities for the company through interactions with other business leaders in the pharmaceutical and high tech industries.

    Nathalie is concurrently CEO, Dompé Holdings, a diversified holding company in Europe with business interests in pharmaceuticals, agriculture, and hi-tech. She sits on the board of several companies including Movendo, Philogen and Dompé farmaceutici. Nathalie graduated with Honors in Business Administration from Bocconi University in Milan. In her free time Nathalie enjoys spending time with her family in the Bay Area, and abroad.

  • ERIONA 2021

    Eriona Gjinukaj

    Chief Operating Officer

    After graduating in Economics at "La Sapienza" University in Rome, she completed her studies with an MBA at Politecnico di Milano.

    In 2005 she joined Bain & Company where she gained a consolidated and internationally recognized expertise in the healthcare sector.

    She joined Dompé in 2018 as Chief Operating Officer (COO) and she’s in charge of leading the company's internationalization project, with an emphasis on biotechnology, following the FDA approval of the first therapy for neurotrophic keratitis.

    The COO coordinates the company’s activities, with the strategic goal of providing patients with highly innovative solutions in response to unmet medical needs.


    Marcello Allegretti

    Chief Scientific Officer

    With a degree in Medical Chemistry from The Sapienza University of Rome, Marcello is a member of the American Chemical Society since 1988 and the Italian Chemistry Society since 2006.

    After a brief period as a university researcher, he joined Dompé as a team leader, followed by a period as Research Director and, since 2009, as a Chief Scientific Officer.

    He leads Dompe’s Research and Development activities and pre-clinical and clinical drug development programs - from active ingredient identification to market authorization - including relationships with international regulatory authorities.

    Marcello also holds a number of university teaching positions and maintains his scientific interests, with published work in over forty scientific journals. He is Associate Editor for several journals.

    He has also filed over thirty international patents.

  • ALVINO 2021

    Serena Alvino

    Chief Legal Officer

    Graduated from the State University of Milan, she obtained an MBA from SDA Bocconi.

    After obtaining the title of lawyer, she began his own activity as an in-house lawyer in Swiss pharmaceutical companies, focusing on worldwide licensing activities

    She returned to Italy in 2009 at Recordati SpA, consolidating her expertise in international contracts.

    She subsequently held the role of Legal and Compliance Director in Reckitt Benckiser Healthcare, with direct responsibility for Italy, Greece and Israel cluster. She is a member of the European Board of Examination (CIPP / E) of the International Association of Privacy Professionals (IAPP).

    Since June 2020 she has been Chief Legal Officer at Dompé and she is responsible for managing all legal issues and the company's contentious.

  • Andreano

    Giuseppe Andreano

    Chief Financial Officer

    Giuseppe Andreano joined Dompé in 2007.

    Following a degree in Business Administration from Bocconi University in Milan, Giuseppe gained experience in administration and financial management with major multinational companies.

    Giuseppe is Dompe’s Chief Financial Officer in charge of administration, budgets and financial control. He also manages IT and purchases.

  • ASTOLFI2021

    Andrea Astolfi

    Chief Human Resources Officer

    Andrea has more than 20 years’ experience in Human Resources, Legal & Compliance Departments of commercial and industrial organizations in the pharma sector. Graduated in Law from the Università Statale di Milano and from Insead Business School’s Leadership Development Program, he is a lawyer articled clerk and has worked extensively in multinational pharmaceutical groups with an excellent track record ranging from HR to compliance.


    Stefano Arena

    Chief Industrial Officer

    Graduated in Biological Science at La Sapienza University in Rome, after a brief period as researcher, Stefano started his career in the pharmaceutical and consumer health business, working for both national and multinational companies, across multiple sites and geographical regions. Coming from Alfasigma, where, as Corporate Quality and Operations, he has played a key role in the post-merger integration process.

    He also worked for Catalent Pharma solutions, a leading provider in the CDMO business, firstly as VP Quality Europe, Japan and Australia and later assuming the role of General Manager of the Italian subsidiary. Stefano joined Dompé in 2020 as Head of Quality Corporate VP, being accountable for strengthening quality governance model and continuously improving company quality standards.

    From 2021 as Chief Industrial Officer, he is in charge of leading the industrial team, supporting the company’s strategic growth, while improving overall manufacturing network efficiency.

  • AMALIA2021

    Amalia Crescenzio

    Chief Compliance Officer

    After graduating with a degree in Chemistry and Pharmaceutical Technology from the University of Bari, Amalia briefly worked as a laboratory assistant before joining the pharmaceutical industry, gaining experience with a number of national and international companies.

    With experience as a Pharmaceutical Representative, in Quality Assurance (in distribution and production), she was also Country Quality Specialist for Amgen’s international team.

    This was followed by the role of Healthcare Compliance Manager, initially for Italy and later for several other European countries.

    Following this she joined Celgene Corporation in Switzerland as Senior Director, EMEA Healthcare Compliance and Audit.

    Amalia became Dompe’s Chief Compliance Officer in 2018 in charge of implementing and managing our corporate compliance program.

  • Ashley 2021

    Ashley Hartmann Kline

    Global Biotech Head for Dompé farmaceutici, S.p.A., General Manager for Dompé U.S.

    Ashley joined Dompé in 2018 to build the US organization. Prior to joining Dompé, Ashley led the Commercial Strategy & Pharmaceutical Development function at Santen, Inc, and previously was responsible for corporate and commercial planning at Adverum Biotechnologies.

    Before that she worked on the Retina Franchise at Genentech. Earlier in her career she worked in the Chicago and San Francisco offices of Bain & Company.

    She earned her MBA from the Kellogg School of Management at Northwestern University and her BA with Distinction from the University of North Carolina at Chapel Hill.

    Ashley spends her free time on the soccer sidelines, helping with math homework, and putting the green thumb she inherited from her grandmother to work in her gardens.

  • Flavio Mantelli v3

    Flavio Mantelli

    Chief Medical Officer

    Graduated in Medicine and Surgery summa cum laude, Flavio completed his specialization program in ophthalmology and a Ph.D. at the Campus Bio-Medico University of Rome. He also completed a postdoctoral fellowship in ocular surface glycobiology at the Schepens Eye Research Institute - Harvard Medical School in Boston.

    Prior to joining Dompé, Flavio researched the application of neurotrophins in ophthalmic and neurodegenerative diseases and was an adjunct associate professor of biology at Temple University in Philadelphia.

    His professional experience includes positions at the IRCCS G.B. Bietti Hospital in Rome as a clinical scientist and as a consultant ophthalmologist at the Campus Biomedico University of Rome and the Cornea and Ocular Surface Unit of the Vita-Salute San Raffaele University of Milan.

    Flavio joined Dompé in 2014, and has been instrumental in developing Oxervate into a revolutionary product for a rare and potentially blinding orphan corneal disease, neurotrophic keratitis. In 2019 he was appointed Chief Medical Officer.

    As Chief Medical Officer and Head of R&D for the Ophthalmology and Neurotrophin platforms, Flavio leads all clinical research and development programs in ophthalmology with particular attention to the applications of NGF in ophthalmic diseases and other therapeutic areas.

    He is the author of numerous scientific publications in international journals.

  • POLIMENI2021

    Davide Polimeni

    Chief Business Unit Officer Primary & Specialty Care

    Davide graduated in Business Administration from Bocconi University in Milan. Since 2015, he has been managing Dompé’s Commercial Operations in Primary Care at national and international level.

    Before taking on this role, he held a number of different marketing and sales positions within the company, focusing on the promotion and development of OTC and ethical drugs.

  • RIZZO2021

    Daniele Rizzo

    Head of Global ICT & Digital Transformation

    Daniele holds a degree in Business Administration from Bocconi University in Milan. He has worked for over 30 years in the ICT transformation and digitization of various companies and industries.

    He began his professional career as a consultant in a leading consulting firm, then as a project and IT manager in a regional group of supermarkets.

    He joined Autogrill in 1999 as ICT project manager responsible for the European branches, and then held the role of CIO for Italy and Europe for over 10 years, carrying out various and recognized digital innovation projects.

    He contributed to the creation of the ICT & Admin shared service center and its transformation into a separate legal entity (AABS spa) which he led as General Manager until 2019.

    Together with G. Bongiorno and G. Vaia he has published the book “CIOs and the digital transformation. A new leadership role "(Springer 2018)

Dompé farmaceutici S.p.A. Single shareholder company / Share capital € 50.000.000,00
REA MI 289519 - A registered company in Milan, Italy / Tax code and VAT number IT00791570153